AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Worldwide product sales ($M) ($M)
Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables
Latest, FY2025
1,199
Period ended Dec 31, 2025
Change on a year earlier
+22.6%
978 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,199 | +22.6% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 978 | +44.5% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 677 | +70.1% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 398 | +96.1% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 203 | +625.0% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 28 | +1,300.0% | Form 6-K FY2020Q4 Earnings Release ↗ |
| FY2019 | Dec 31, 2019 | 2 | – | Form 20-F (filed 2020-03-03) ↗ |
Breakdown
What makes up breztri aerosphere (budesonide/glycopyrronium/formoterol) — worldwide product sales ($m)
- Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Worldwide YoY actual (%)23.0% · FY2025
- Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Worldwide YoY CER (%)22.0% · FY2025
- Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — US product sales ($M)614 · FY2025
- Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Emerging Markets product sales ($M)298 · FY2025
- Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Europe product sales ($M)191 · FY2025
- Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Established RoW product sales ($M)96 · FY2025
Cite this data
StockData. (2026). AstraZeneca Breztri Aerosphere (budesonide/glycopyrronium/formoterol) — Worldwide product sales ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_breztri_world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.